Chugai Pharmaceutical Co., Ltd. (4519.T)
JPY 6696.0
(-1.72%)
JPY 6696.0
(-1.72%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1932.54 Billion JPY | 3.36% |
| 2022 | 1869.75 Billion JPY | 21.52% |
| 2021 | 1538.69 Billion JPY | 24.54% |
| 2020 | 1235.49 Billion JPY | 16.68% |
| 2019 | 1058.91 Billion JPY | 15.16% |
| 2018 | 919.54 Billion JPY | 7.87% |
| 2017 | 852.47 Billion JPY | 5.73% |
| 2016 | 806.28 Billion JPY | 2.4% |
| 2015 | 787.4 Billion JPY | 6.47% |
| 2014 | 739.53 Billion JPY | 6.07% |
| 2013 | 697.21 Billion JPY | 18.63% |
| 2012 | 587.71 Billion JPY | 10.17% |
| 2011 | 533.48 Billion JPY | 5.01% |
| 2010 | 508.01 Billion JPY | -6.02% |
| 2009 | 540.54 Billion JPY | 12.96% |
| 2008 | 478.51 Billion JPY | 4.27% |
| 2007 | 458.94 Billion JPY | -0.69% |
| 2006 | 462.12 Billion JPY | 1.24% |
| 2005 | 456.44 Billion JPY | 10.94% |
| 2004 | 411.44 Billion JPY | 1.54% |
| 2003 | 405.19 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1897.76 Billion JPY | -1.8% |
| 2024 Q3 | 2069.73 Billion JPY | 0.46% |
| 2024 Q2 | 2060.16 Billion JPY | 8.56% |
| 2023 Q2 | 1831.59 Billion JPY | 3.36% |
| 2023 Q3 | 1817.64 Billion JPY | -0.76% |
| 2023 FY | 1932.54 Billion JPY | 3.36% |
| 2023 Q1 | 1771.97 Billion JPY | -5.23% |
| 2023 Q4 | 1932.54 Billion JPY | 6.32% |
| 2022 Q1 | 1584.94 Billion JPY | 3.01% |
| 2022 FY | 1869.75 Billion JPY | 21.52% |
| 2022 Q2 | 1625.6 Billion JPY | 2.57% |
| 2022 Q3 | 1700.81 Billion JPY | 4.63% |
| 2022 Q4 | 1869.75 Billion JPY | 9.93% |
| 2021 Q3 | 1353.36 Billion JPY | 6.08% |
| 2021 Q4 | 1538.69 Billion JPY | 13.69% |
| 2021 FY | 1538.69 Billion JPY | 24.54% |
| 2021 Q1 | 1144.62 Billion JPY | -7.36% |
| 2021 Q2 | 1275.76 Billion JPY | 11.46% |
| 2020 FY | 1235.49 Billion JPY | 16.68% |
| 2020 Q4 | 1235.49 Billion JPY | 8.75% |
| 2020 Q3 | 1136.1 Billion JPY | 5.97% |
| 2020 Q2 | 1072.14 Billion JPY | 2.54% |
| 2020 Q1 | 1045.6 Billion JPY | -1.26% |
| 2019 FY | 1058.91 Billion JPY | 15.16% |
| 2019 Q2 | 986.62 Billion JPY | 5.83% |
| 2019 Q3 | 1025.33 Billion JPY | 3.92% |
| 2019 Q4 | 1058.91 Billion JPY | 3.27% |
| 2019 Q1 | 932.24 Billion JPY | 1.38% |
| 2018 FY | 919.54 Billion JPY | 7.87% |
| 2018 Q3 | 890.84 Billion JPY | 2.0% |
| 2018 Q4 | 919.54 Billion JPY | 3.22% |
| 2018 Q1 | 852.88 Billion JPY | 0.05% |
| 2018 Q2 | 873.34 Billion JPY | 2.4% |
| 2017 Q2 | 821.69 Billion JPY | 2.94% |
| 2017 Q4 | 852.47 Billion JPY | 4.22% |
| 2017 FY | 852.47 Billion JPY | 5.73% |
| 2017 Q1 | 798.23 Billion JPY | -1.0% |
| 2017 Q3 | 817.94 Billion JPY | -0.46% |
| 2016 Q3 | 769.86 Billion JPY | 0.39% |
| 2016 FY | 806.28 Billion JPY | 2.4% |
| 2016 Q4 | 806.28 Billion JPY | 4.73% |
| 2016 Q2 | 766.88 Billion JPY | 0.58% |
| 2016 Q1 | 762.42 Billion JPY | -3.17% |
| 2015 Q4 | 787.4 Billion JPY | 4.5% |
| 2015 Q2 | 744.31 Billion JPY | 2.35% |
| 2015 Q3 | 753.49 Billion JPY | 1.23% |
| 2015 Q1 | 727.25 Billion JPY | -1.66% |
| 2015 FY | 787.4 Billion JPY | 6.47% |
| 2014 FY | 739.53 Billion JPY | 6.07% |
| 2014 Q4 | 739.53 Billion JPY | 3.59% |
| 2014 Q3 | 713.92 Billion JPY | 0.82% |
| 2014 Q2 | 708.15 Billion JPY | 0.94% |
| 2014 Q1 | 701.56 Billion JPY | 0.62% |
| 2013 Q1 | 632.22 Billion JPY | 7.57% |
| 2013 FY | 697.21 Billion JPY | 18.63% |
| 2013 Q3 | 671.61 Billion JPY | 2.62% |
| 2013 Q4 | 697.21 Billion JPY | 3.81% |
| 2013 Q2 | 654.49 Billion JPY | 3.52% |
| 2012 Q1 | 532.47 Billion JPY | -0.19% |
| 2012 Q4 | 587.71 Billion JPY | 8.02% |
| 2012 Q3 | 544.1 Billion JPY | 0.36% |
| 2012 FY | 587.71 Billion JPY | 10.17% |
| 2012 Q2 | 542.15 Billion JPY | 1.82% |
| 2011 Q4 | 533.48 Billion JPY | -0.18% |
| 2011 Q3 | 534.42 Billion JPY | 0.96% |
| 2011 Q1 | 520.27 Billion JPY | 2.41% |
| 2011 Q2 | 529.35 Billion JPY | 1.75% |
| 2011 FY | 533.48 Billion JPY | 5.01% |
| 2010 Q4 | 508.01 Billion JPY | 1.36% |
| 2010 FY | 508.01 Billion JPY | -6.02% |
| 2010 Q1 | 511.13 Billion JPY | -5.44% |
| 2010 Q2 | 507.16 Billion JPY | -0.78% |
| 2010 Q3 | 501.17 Billion JPY | -1.18% |
| 2009 Q4 | 540.54 Billion JPY | 6.97% |
| 2009 Q2 | 501.74 Billion JPY | 4.8% |
| 2009 Q3 | 505.3 Billion JPY | 0.71% |
| 2009 Q1 | 478.74 Billion JPY | 0.0% |
| 2009 FY | 540.54 Billion JPY | 12.96% |
| 2008 FY | 478.51 Billion JPY | 4.27% |
| 2007 FY | 458.94 Billion JPY | -0.69% |
| 2006 FY | 462.12 Billion JPY | 1.24% |
| 2005 FY | 456.44 Billion JPY | 10.94% |
| 2004 FY | 411.44 Billion JPY | 1.54% |
| 2003 FY | 405.19 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 1025.94 Billion JPY | -88.368% |
| Astellas Pharma Inc. | 3569.6 Billion JPY | 45.861% |
| Ono Pharmaceutical Co., Ltd. | 913.66 Billion JPY | -111.515% |
| Santen Pharmaceutical Co., Ltd. | 435.69 Billion JPY | -343.551% |
| JCR Pharmaceuticals Co., Ltd. | 102.22 Billion JPY | -1790.465% |
| Daiichi Sankyo Company, Limited | 3461.13 Billion JPY | 44.164% |
| Otsuka Holdings Co., Ltd. | 3361.24 Billion JPY | 42.505% |
| Perseus Proteomics Inc. | 1.69 Billion JPY | -113994.674% |